Is Combined Pretransplantation Seropositivity of Kidney Transplant Recipients for Cytomegalovirus Antigens (pp150 and pp28) a Predictor for Protection against Infection?

Antiviral agents for preventing cytomegalovirus infection in pediatric renal transplant recipients: A systematic review

Background and Objective: Cytomegalovirus (CMV) infections are associated with severe morbidity and mortality in patients, especially pediatric renal transplantation patients. The use of immunosuppressive agents places these patients at the risk of viral infections. As cytomegalovirus infection influences the graft outcome, adopting useful strategies for limiting this virus after transplantatio...

Covid-19 infection in kidney transplant recipients: a case report

Cytomegalovirus infection in transplant recipients

Cytomegalovirus infection is a frequent complication after transplantation. This infection occurs due to transmission from the transplanted organ, due to reactivation of latent infection, or after a primary infection in seronegative patients and can be defined as follows: latent infection, active infection, viral syndrome or invasive disease. This condition occurs mainly between 30 and 90 days ...

Holoendemic cytomegalovirus infection in renal transplant recipients.

A prospective study of epidemiology and pathogenesis of cytomegalovirus (CMV) infections in transplant recipients, previously reported for 30 patients (Clin. Res. XXII, 441A, 1974), has been extended to include 35 patients who have been studied clinically and virologically for 5 to 19 months after renal transplantation (RT) (except three patients who died within three months after RT). Active C...

Cytomegalovirus infection in renal transplant recipients.

We have retrospectively analyzed the incidence of cytomegalovirus (CMV) infection in 250 consecutive renal allograft transplants performed in 244 recipients. The mean follow-up was 35.1+/-25.4 months. Immunosuppression was cyclosporine- or tacrolimus-based triple therapy. CMV infection prophylaxis with ganciclovir for 3 months post transplant was prescribed in CMV-seronegative recipients of all...